Amerimas Home Products, Inc.
1,611Patents
0Active
1,611Granted
46Portfolio score
Filing activity: Jun 2, 1966 → Feb 25, 2004
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5120842A | Silyl ethers of rapamycin | Human Necessities | 289 | Expired |
| US5362718A | Rapamycin hydroxyesters | Human Necessities | 288 | Expired |
| US3972995A | Dosage form | Human Necessities | 268 | Expired |
| US5516781A | Method of treating restenosis with rapamycin | Human Necessities | 257 | Expired |
| US5100883A | Fluorinated esters of rapamycin | Chemistry; Metallurgy | 252 | Expired |
| US5118678A | Carbamates of rapamycin | Chemistry; Metallurgy | 248 | Expired |
| US5151413A | Rapamycin acetals as immunosuppressant and antifungal agents | Chemistry; Metallurgy | 245 | Expired |
| US5118677A | Amide esters of rapamycin | Human Necessities | 241 | Expired |
| US5288711A | Method of treating hyperproliferative vascular disease | Human Necessities | 224 | Expired |
| US5177203A | Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents | Chemistry; Metallurgy | 203 | Expired |
| US4885171A | Use of rapamycin in treatment of certain tumors | Human Necessities | 185 | Expired |
| US4229447A | Intraoral methods of using benzodiazepines | Human Necessities | 177 | Expired |
| US4794001A | Formulations providing three distinct releases | Human Necessities | 173 | Expired |
| US5233036A | Rapamycin alkoxyesters | Chemistry; Metallurgy | 172 | Expired |
| US5130307A | Aminoesters of rapamycin | Human Necessities | 171 | Expired |
| US5080899A | Method of treating pulmonary inflammation | Human Necessities | 170 | Expired |
| US5221670A | Rapamycin esters | Human Necessities | 169 | Expired |
| US5385909A | Heterocyclic esters of rapamycin | Human Necessities | 166 | Expired |
| US5168876A | Connector device for use in monitoring fetal heart rate | Emerging Cross-Sectional Technologies | 165 | Expired |
| US5302584A | Carbamates of rapamycin | Human Necessities | 163 | Expired |
| US5563146A | Method of treating hyperproliferative vascular disease | Human Necessities | 160 | Expired |
| US5260300A | Rapamycin carbonate esters as immuno-suppressant agents | Human Necessities | 159 | Expired |
| US5385908A | Hindered esters of rapamycin | Human Necessities | 158 | Expired |
| US5023262A | Hydrogenated rapamycin derivatives | Chemistry; Metallurgy | 153 | Expired |
| US5321009A | Method of treating diabetes | Human Necessities | 152 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.